Literature DB >> 32161123

Th17 lymphocytes drive vascular and neuronal deficits in a mouse model of postinfectious autoimmune encephalitis.

Maryann P Platt1,2, Kevin A Bolding3, Charlotte R Wayne2,4, Sarah Chaudhry2, Tyler Cutforth2, Kevin M Franks5, Dritan Agalliu6,7.   

Abstract

Antibodies against neuronal receptors and synaptic proteins are associated with a group of ill-defined central nervous system (CNS) autoimmune diseases termed autoimmune encephalitides (AE), which are characterized by abrupt onset of seizures and/or movement and psychiatric symptoms. Basal ganglia encephalitis (BGE), representing a subset of AE syndromes, is triggered in children by repeated group A Streptococcus (GAS) infections that lead to neuropsychiatric symptoms. We have previously shown that multiple GAS infections of mice induce migration of Th17 lymphocytes from the nose into the brain, causing blood-brain barrier (BBB) breakdown, extravasation of autoantibodies into the CNS, and loss of excitatory synapses within the olfactory bulb (OB). Whether these pathologies induce functional olfactory deficits, and the mechanistic role of Th17 lymphocytes, is unknown. Here, we demonstrate that, whereas loss of excitatory synapses in the OB is transient after multiple GAS infections, functional deficits in odor processing persist. Moreover, mice lacking Th17 lymphocytes have reduced BBB leakage, microglial activation, and antibody infiltration into the CNS, and have their olfactory function partially restored. Th17 lymphocytes are therefore critical for selective CNS entry of autoantibodies, microglial activation, and neural circuit impairment during postinfectious BGE.

Entities:  

Keywords:  Th17 lymphocyte; autoimmune encephalitis; blood–brain barrier; olfactory circuitry; postinfectious basal ganglia encephalitis

Mesh:

Substances:

Year:  2020        PMID: 32161123      PMCID: PMC7104239          DOI: 10.1073/pnas.1911097117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Sydenham's chorea; a clinicopathologic study.

Authors:  H S COLONY; N MALAMUD
Journal:  Neurology       Date:  1956-09       Impact factor: 9.910

2.  Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells.

Authors:  Svetlana M Stamatovic; Richard F Keep; Michael M Wang; Ivana Jankovic; Anuska V Andjelkovic
Journal:  J Biol Chem       Date:  2009-05-07       Impact factor: 5.157

3.  Mitral cells in the olfactory bulb are mainly excited through a multistep signaling path.

Authors:  David H Gire; Kevin M Franks; Joseph D Zak; Kenji F Tanaka; Jennifer D Whitesell; Abigail A Mulligan; René Hen; Nathan E Schoppa
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

Review 4.  A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.

Authors:  Ralph Stadhouders; Erik Lubberts; Rudi W Hendriks
Journal:  J Autoimmun       Date:  2017-12-22       Impact factor: 7.094

5.  Caveolin1 Is Required for Th1 Cell Infiltration, but Not Tight Junction Remodeling, at the Blood-Brain Barrier in Autoimmune Neuroinflammation.

Authors:  Sarah E Lutz; Julian R Smith; Dae Hwan Kim; Carl V L Olson; Kyle Ellefsen; Jennifer M Bates; Sunil P Gandhi; Dritan Agalliu
Journal:  Cell Rep       Date:  2017-11-21       Impact factor: 9.423

6.  LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory.

Authors:  Mar Petit-Pedrol; Josefine Sell; Jesús Planagumà; Francesco Mannara; Marija Radosevic; Holger Haselmann; Mihai Ceanga; Lidia Sabater; Marianna Spatola; David Soto; Xavier Gasull; Josep Dalmau; Christian Geis
Journal:  Brain       Date:  2018-11-01       Impact factor: 13.501

7.  CNS autoimmune disease after Streptococcus pyogenes infections: animal models, cellular mechanisms and genetic factors.

Authors:  Tyler Cutforth; Mellissa Mc DeMille; Ilir Agalliu; Dritan Agalliu
Journal:  Future Neurol       Date:  2016-12

8.  Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties.

Authors:  Chittappen K Prajeeth; Julius Kronisch; Reza Khorooshi; Benjamin Knier; Henrik Toft-Hansen; Viktoria Gudi; Stefan Floess; Jochen Huehn; Trevor Owens; Thomas Korn; Martin Stangel
Journal:  J Neuroinflammation       Date:  2017-10-16       Impact factor: 8.322

9.  Olfactory dysfunction as a prognostic marker for disability progression in Multiple Sclerosis: An olfactory event related potential study.

Authors:  Rosella Ciurleo; Lilla Bonanno; Simona De Salvo; Laura Romeo; Carmela Rifici; Edoardo Sessa; Giangaetano D'Aleo; Margherita Russo; Placido Bramanti; Silvia Marino; Fabrizia Caminiti
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

10.  Olfactory dysfunction in Alzheimer's disease Systematic review and meta-analysis.

Authors:  Maren de Moraes E Silva; Pilar Bueno Siqueira Mercer; Maria Carolina Zavagna Witt; Renata Ramina Pessoa
Journal:  Dement Neuropsychol       Date:  2018 Apr-Jun
View more
  20 in total

Review 1.  Inflammatory reflex disruption in COVID-19.

Authors:  Khalil Hajiasgharzadeh; Mahdi Jafarlou; Behzad Mansoori; Narges Dastmalchi; Behzad Baradaran; Alireza Khabbazi
Journal:  Clin Exp Neuroimmunol       Date:  2022-04-29

2.  NRM 2021 Abstract Booklet.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2021-12       Impact factor: 6.960

3.  In Search of the Holy Grail: A Specific Diagnostic Test for Rheumatic Fever.

Authors:  David J McMillan; Rukshan A M Rafeek; Robert E Norton; Michael F Good; Kadaba S Sriprakash; Natkunam Ketheesan
Journal:  Front Cardiovasc Med       Date:  2021-05-14

4.  Effects of RORγt overexpression on the murine central nervous system.

Authors:  Tetsuya Sasaki; Rei Nagata; Satoru Takahashi; Yosuke Takei
Journal:  Neuropsychopharmacol Rep       Date:  2021-02-06

Review 5.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System.

Authors:  Fernanda G De Felice; Fernanda Tovar-Moll; Jorge Moll; Douglas P Munoz; Sergio T Ferreira
Journal:  Trends Neurosci       Date:  2020-04-21       Impact factor: 13.837

6.  Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.

Authors:  Carlos Manuel Romero-Sánchez; Inmaculada Díaz-Maroto; Eva Fernández-Díaz; Álvaro Sánchez-Larsen; Almudena Layos-Romero; Jorge García-García; Esther González; Inmaculada Redondo-Peñas; Ana Belén Perona-Moratalla; José Antonio Del Valle-Pérez; Julia Gracia-Gil; Laura Rojas-Bartolomé; Inmaculada Feria-Vilar; María Monteagudo; María Palao; Elena Palazón-García; Cristian Alcahut-Rodríguez; David Sopelana-Garay; Yóscar Moreno; Javaad Ahmad; Tomás Segura
Journal:  Neurology       Date:  2020-06-01       Impact factor: 9.910

7.  Hypoferritinemia and iron deficiency in youth with pediatric acute-onset neuropsychiatric syndrome.

Authors:  Avis Chan; Hannah Karpel; Ellen Spartz; Theresa Willett; Bahare Farhadian; Michael Jeng; Margo Thienemann; Jennifer Frankovich
Journal:  Pediatr Res       Date:  2020-08-03       Impact factor: 3.756

8.  Group A streptococcal antigen exposed rat model to investigate neurobehavioral and cardiac complications associated with post-streptococcal autoimmune sequelae.

Authors:  Rukshan A M Rafeek; Catherine M Lobbe; Ethan C Wilkinson; Adam S Hamlin; Nicholas M Andronicos; David J McMillan; Kadaba S Sriprakash; Natkunam Ketheesan
Journal:  Animal Model Exp Med       Date:  2021-04-08

9.  Autoantibody Biomarkers for Basal Ganglia Encephalitis in Sydenham Chorea and Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infections.

Authors:  Jennifer L Chain; Kathy Alvarez; Adita Mascaro-Blanco; Sean Reim; Rebecca Bentley; Rebecca Hommer; Paul Grant; James F Leckman; Ivana Kawikova; Kyle Williams; Julie A Stoner; Susan E Swedo; Madeleine W Cunningham
Journal:  Front Psychiatry       Date:  2020-06-24       Impact factor: 4.157

Review 10.  Update on Neurological Manifestations of SARS-CoV-2.

Authors:  Hisham M Valiuddin; Almir Kalajdzic; James Rosati; Kevin Boehm; Dominique Hill
Journal:  West J Emerg Med       Date:  2020-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.